Bioequivalence challenges in development of fixed-dose combination products : looking beyond reformulation

INTRODUCTION: Bioequivalence study is a critical step in the development of novel fixed-dose combination products (FDCPs). While bioequivalence of prototype FDCP to the approved monocomponent products facilitates speedier development and approval, lack of bioequivalence often leads to development de...

Full description

Bibliographic Details
Published in:Expert opinion on drug delivery, Vol. 9, No. 3 (2012), p. 325-32
Main Author: Dubey, Rajesh (Author)
Format: electronic Article
Item Description:Date Completed 10.04.2013
Date Revised 01.12.2018
published: Print-Electronic
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Physical Description:Online-Ressource
QR Code: Show QR Code